Vancomycin biodegradable poly(lactide-co-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading andin vitrorelease
- 1 January 2005
- journal article
- research article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 22 (8) , 841-852
Abstract
The present study investigates vancomycin microencapsulation in biodegradable PLAGA microparticles. To optimize encapsulation efficiency by the double emulsion (w/o/w) solvent evaporation/extraction process, two parameters were studied: surfactant (Span® 80) rate and external aqueous phase saturation. In vitro dissolution studies, laser granulometry and scanning electron microscopy were performed to characterize the microparticles. The best results were obtained by stabilizing the first emulsion with 0.5% Span® 80 and saturating the external phase with sodium chloride. Such parameters allowed a 95% drug encapsulation efficiency. This process yielded round microparticles with a mean diameter of ∼170 µm and presenting a smooth surface without any pores. Moreover, this formulation induces a sustained drug release at a constant rate over a period of 10 days. Such materials could be associated with biphasic calcium phosphate granules to form an antibiotic-loaded injectable bone substitute offering a long-term activity in situ.Keywords
This publication has 20 references indexed in Scilit:
- Microparticle formation and its mechanism in single and double emulsion solvent evaporationJournal of Controlled Release, 2004
- Preparation of poly(?-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acidInternational Journal of Pharmaceutics, 2003
- Vancomycin encapsulation in biodegradable poly(ε-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibilityBiomaterials, 2003
- A new injectable bone substitute combining poly(ε-caprolactone) microparticles with biphasic calcium phosphate granulesBiomaterials, 2001
- Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation methodBiomaterials, 2001
- Protein release from poly(ε-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: A comparative studyJournal of Biomaterials Science, Polymer Edition, 1997
- Dynamic compaction: a new process to compact therapeutic agent-loaded calcium phosphatesBiomaterials, 1997
- A self-setting TTCP-DCPD apatite cement for release of vancomycinJournal of Biomedical Materials Research, 1996
- Microencapsulation of nitrofurantoin in poly(ϵ-caprolactone): tableting and in vitro release studiesInternational Journal of Pharmaceutics, 1987
- Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheresJournal of Microencapsulation, 1987